Preserving the intellectual output & resources of the University of Missouri.
Monitoring Therapy for Patients with Alzheimer's Disease
MOspace/Manakin Repository
Breadcrumbs Navigation
Monitoring Therapy for Patients with Alzheimer's Disease
Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/3979
| Title: | Monitoring Therapy for Patients with Alzheimer's Disease |
| Author: | Raetz, Jaqueline; Luft, Eric v.d. (Eric von der), 1952- |
| Keywords: |
cognitive function
global function cholinesterase inhibitor |
| Date: | 2007-06 |
| Publisher: | Family Physicians Inquiries Network |
| Citation: | American Family Physician, 75(11) 2007. |
| Abstract: | Patients with Alzheimer's disease who undergo treatment of any kind should be monitored eight weeks after initiation of therapy and at least every six months thereafter. (Strength of Recommendation: C, based on expert opinion and extrapolation from drug effectiveness studies) |
| URI: | http://hdl.handle.net/10355/3979 |
Items in MOspace are protected by copyright, with all rights reserved, unless otherwise indicated.
This item appears in the following Collection(s)
-
Clinical Inquiries, 2007 [80]
The items in this collection constitute volume 56 of Clinical Inquiries.